Summary
Administration of glucocorticoids is effective and necessary in various diseases, but the appearance of side effects may compromise its results. Timing as well as dosing designed to obtain, for the highest number of patients, maximal beneficial effects with minimal undesired effects, is particularly pertinent to long-term corticosteroid therapy, in view of the rhythms exhibited by the endogenous secretion of adrenal cortical and coordinating hormones, primarily ACTH. In experimental animals, properly-timed circadian treatment can be preferred to alternate-day treatment for avoiding certain side effects. To secure the desired effect each day rather than only on alternate days, a chronobiologically correct corticosteroid therapy seeks the best compromise between timing for most of the desired and least of the undesired effects. This was the aim in the design of a chronopluricorticoid drug, with the time specification on its label. The clinical use of this preparation allowed the inferential statistical demonstration of a rhythmic circadian organization maintained during therapy, while the pharmacological results gained were similar to those obtained by the conventional administration of larger doses of corticoids.
Similar content being viewed by others
References
Agrimonti F., Angeli A., Fraria R., Fazzari A. M., Tamagnone C., Fornaro D., Ceresa F.: Circannual rhythmicities of cortisol levels in the peripheral plasma of healthy adult subjects—Chronobiologia9, 107, 1982.
Agrimonti F., Boggio-Bertinet D., Balzola F., Angeli A.: Circadian profile of plasma cortisol and aldosterone in post-traumatic comatose patients under high-dose dexamethasone treatment—J. endocr. Invest.4, 49, 1981.
Anceli A.: Rhythmicity of pituitary hormone secretion. In:Motta M., Zanisi M., Piva F. (Eds): Pituitary hormones and related peptides. Serono Symposium no. 49. Academic Press, London, New York and San Francisco, 1982; p. 319.
Bixby L., Levi F., Haus R., Sackett L., Haus E., Halberg F., Hrushesky W.: Circaseptan aspects of cisplatine (CP) murine nephrotoxicity—Chronobiologia6, 80, 1979. (Abstract).
Carter M. E., James V. H. T.: Effect of alternate-day, single dose corticosteroid therapy on pituitary-adrenal function—Ann. rheum. Dis.31, 379, 1972.
Ceresa F.: Chronopharmacological attempt to avoid the inhibitory corticoid effect during long-term treatment—Chronobiologia1 (Suppl. 1), 271, 1974.
Ceresa F., Angeli A.: Chronothérapie corticoide. In:Mirouze J. (Ed.): XIV Congres International de Thérapeutique. L'Expansion Scientifique Française, Paris, 1977; p. 211.
Ceresa F., Angeli A., Boccuzzi G., Molino G.: Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition—J. clin. Endocr.29, 1074, 1969.
Copinschi G., Leclercq R., Goldstein J., Robyn C., Delsir D., De Laet M. H., Virasoro E., Vanhaelst L., L'Hermite M., Van Cauter E.: Seasonal modifications of circadian and ultradian variations of ACTH, cortisol, βMSH, hPRL and TSH in normal man— Chronobiologia4, 106, 1977. (Abstract).
Daly J. R., Evans J. I.: Daily rhythms of steroid and associated pituitary hormones in man and their relationship to sleep—Advanc. Steroid Biochem. Pharmacol.4, 61, 1974.
De Vecchi A., Cantaluppi A., Montagnino G., Tarantino A., Maestri O., Ponticelli C.: Long-term comparison between single-morning daily and alternate-day steroid treatment in cadaver kidney recipients—Transplant. Proc.12, 327, 1980.
De Vecchi A., Carandente F., Fryd D. S., Halberg F., Sutherland D. E., Howard R. J., Simmons R. L., Najarian J. S.: Circaseptan (about 7-day) rhythm in human kidney allograft rejection in different geographic locations. In:Reinberg A., Halberg F. (Eds): Chronopharmacology. Pergamon Press, Oxford, 1979; p. 193.
De Vecchi A., Halberg F., Sothern R. B., Cantaluppi A., Ponticelli C.: Circasepian rhythmic aspects of rejection in treated patients with kidney transplant. In:Walker C. A., Winget C. M., Soliman K. F. A. (Eds): Chronopharmacology and chronotherapeutics. Florida A and M University Foundation, Tallahassee, 1981; p. 339.
De Vecchi A., Ponticelli C.: A survey of current steroid regimens for transplant patients— Heart Transplant.2, 64, 1982.
Di Raimondo V. C., Forsham P. H.: Some clinical implications of the spontaneous diurnal variation in adrenal cortical secretory activity—Amer. J. Med.21, 321, 1956.
Eratalay J. K., Simmons D. J., El-Mofty S. K., Rosenberg G. D., Nelson W., Haus E., Halberg F.: Methylprednisolone chronopharmacology: bone growth in the rat mandible following every-day or alternate-day schedules—Arch. oral Biol.26, 769, 1981.
Fauci A. S.: Alternate-day corticosteroid therapy—Amer. J. Med.64, 729, 1978.
Frev F. J., Amend W. J. C., Lozada F., Frey B. M., Holford N. H. G., Benet L. Z.: Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and non-cushingoid patients—Europ. J. clin. Pharmacol.21, 235, 1981.
Halberg F.: Some physiological and clinical aspects of 24-hour periodicity—J. Lancet (USA)73, 20, 1953.
Halberg F.: Organisms as circadian systems; temporal analysis of their physiologic and pathologic responses, including injury and death. In: Walter Reed Army Institute of Research Symposium, Medical Aspects of Stress in the Military Climate. April 1964; p. 1.
Halberg F., Halberg E., Barnum C. P., Bittner J. J.: Physiologic 24-hour periodicity in human beings and mice, the lighting regimen and daily routine. In:Withrow R. B. (Ed.): Photoperiodism and related phenomena in plants and animals. Ed. Publ. # 55, Amer. Ass. Advanc. Sci., Washington, D.C., 1959; p. 803.
Halberg F., Halberg E., Halberg J.: Collateral-interacting hierarchy of rhythm coordination at different organization levels, changing schedules and aging. In:Suda M., Hayaishi O., Nakagawa H. (Eds): Biological rhythms and their central mechanism. Naito Foundation, Elsevier/North-Holland Biomedical Press, Arnsterdam, 1979; p. 421. (See also discussion pp. 435–438).
Halberg F., Halberg E., Herold M., Vecsei P., Günther R., Reinberg A.: Toward a clinospectrometry of conventional and novel effects of ACTH 1·17—Synchrodyn®—in rodents and human beings. In:Takahashi R., Walker C., Halberg F. (Eds): Toward chronopharmacology. Proc. 8th IUPHAR Congr. and Sat. Symposia, Nagasaki July 27–28, 1981. Pergamon Press, Oxford-New York, 1932; p. 119.
Halberg F., Halberg E., Runge W., Wicks J., Cadotte L., Yunis E., Katinas G., Stutman O.: Transplant chronobiology. In:Scheving L. E., Halberg F., Pauly J. E. (Eds): Chronobiology. Igaku Shoin Ltd., Tokyo, 1974; p. 320.
Halberg F., Lubanovic W. A., Sothern R. B., Brockway B., Powell E. W., Pasley J. N., Scheving L. E. Nornifensine chronopharmacology, schedule shifts and circadian temperature rhythms in di-suprachiasmatically lesioned rats. Modeling emotional chronopathology and chronotherapy—Chronobiologia6, 405, 1979.
Halberg F., Reinberg A.: Rythmes circadiens et rythmes de basse fréquence en physiologie humaine—J. Physiol. (Paris),59, 117, 1967.
Harter J. G.: Corticosteroids, their physiologic use in allergic disease—N.Y. St. J. Med.66, 827, 1966.
Harter J. G., Reddy W. J., Thorn G. W.: Studies on an intermittent corticosteroid dosage regimen—New Engl. J. Med.296, 591, 1963.
Haus E., Halberg F.: Endocrine rhythms. In:Scheving L. E., Halberg F. (Eds): Chronobiology. Principles and applications to shifts in schedules. Sijthoff and Noordhoff, Alphen aan den Rijn, The Netherlands, and Rockville, Md., 1980; p. 137.
Hopkins H.A., Ritenour R. E., MacLeod M., Looney W. B.: The effect of varying the time between irradiation and cyclophosphamide on growth response of hepatoma 3924 A—Int. J. Radiat. Oncol. Biol. Phys.5, 1455, 1979.
Hunder G. G., Sheps S. G., Allen G. L., Joyce J. W.: Daily and alternate day corticosteroid regimens in treatment of giant cell arteritis—Ann. intern. Med.82, 513,1975.
Kaneko M., Kaneko K., Shinsako J., Dallman M. F.: Adrenal sensitivity to adrenocorticotropi (ACTH) varies diurnally—Endocrinology109, 70, 1981.
Knapp M. S., Pownall R.: Chronobiology, pharmacology and the immune system—Int. J. Immunopharmacol.2, 91, 1980.
Krieger D. T.: Rhythms in CRF, ACTH, and corticosteroids. In:Kriecer D. T. (Ed.): Endocrine rhythms. Raven Press, New York, 1979; p. 123.
Kriecer D. T., Allen W., Rizzo F.: Characterization of the normal pattern of plasma corticosteroid levels—J. clin. Endocr.32, 266, 1971.
Levi F., Halberg F.: Circaseptan (about-7-day) bioperiodicity—spontaneous and reactive— and the search for pacemakers—La Ricerca Clin. Lab.12, 323, 1982.
Liddle G. W.: The adrenals. In:Williams R. M. (Ed.): Textbook of endocrinology, W. B. Saunders Co., Philadelphia, London and Toronto, 1981; 6th ed., chapter. 5, p. 249.
MacGill P. E., Grieg W. R., Browning M., Boyle J. A.: Plasma cortisol response to Synacthen (ACTH 1–24 Ciba) at different times of the day in patients with rheumatic disease.— Ann. rheum. Dis.26, 123, 1967.
Meier A. H.: Daily variation in concentration of plasma corticosteroids in hypophysectomized rats—Endocrinology98, 1475, 1976.
Menaker M., Takahashi J. S., Eskin A.: The physiology of circadian pacemakers—Ann. Rev. Physiol.40, 501, 1978.
Montalbetti N.: Non-interference in circadian rhythm during clinical use of corticoids— Chronobiologia1 (Suppl. 1), 281, 1974.
Moore-Ede M. C.: Circadian rhythms of drug effectiveness and toxicity—Clin. Pharmacol. Ther.14, 925, 1973.
Nichols T., Nugent C. A., Tyler G. H.: Diurnal variation in suppression of adrenal function by glucocorticoids—J. clin. Endocr.25, 343, 1965.
Pincus G.: A diurnal rhythm in the excretion of urinary ketosteroids by young men—J. clin. Endocr.3, 195, 1943.
Ratte J., Halberg F., Kühl J. F. W., Najarian J. S.: Circadian and circaseptan variations in rat kidney allograft rejection. In:McGovern J., Reinberg A., Smolensky M. (Eds) Chronobiology in allergy and immunology. C. Thomas, Springfield, 1977; p. 250.
Reed W. P., Lucas Z. J., Cohn R.: Alternate-day prednisone therapy after renal transplantation —Lanceti, 747, 1970.
Rees L. H., Holdaway I. M., Phenekos C., Besser G. M., Landon J.: ACTH secretion and clinical investigations. In:Franchimont P. (Ed.): Aspects of hypothalamic regulation of endocrine function. Schattauer Verlag, Stuttgart and New York, 1975; p. 457.
Reinberg A., Gervais P., Chaussade M., Fraboulet G., Duburque B.: Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma—J. Allergy. (In press).
Reinberg A., Guillemant N. J., Touitou Y., Dupont M., Lagoguey M., Bourgeois P., Briere L., Fraboulet G., Guillet P.: Clinical chronopharmacology of ACTH-1-17. Effects on plasma cortisol and urinary 17-hydroxycorticosteroids—Chronobiologia7, 513, 1980.
Reinberg A., Guillet P., Gervais P., Ghata J., Vignaud D., Abulker C.: One-month chronocorticotherapy (Dutimelan® 8.15 mite). Control of the asthmatic condition without adrenal suppression and circadian rhythm alteration—Chronobiologia4, 295, 1977.
Reinberg A., Halberg F., Falliers C.: Circadian timing of methylprednisolone effects in asthmatic boys—Chronobiologia1, 333, 1974.
Reinberg A., Lagoguey M.: Annual endocrine rhythms in healthy young adult men: thein implication in human biology and medicine. In:Assenmacher I., Farner D. S. (Eds): Environmental endocrinology. Springer-Verlag, Berlin, Heidelberg and New York 1978: p. 113.
Reinberg A., Touitou Y., Levi F.: Rythmes circadiens et circannuels d'epreuves fontionnelles en endocrinologie.—Ann. Endocr. (Paris). (In press).
Rietveld W. J., Groos G. A.: The central neural regulation of circadian rhythms. In:Scheving L. E., Halberg F. (Eds): Chronobiology. Principles and applications to shifts in schedules. Sijthoff and Noordhoff, Alphen aan den Rijn, The Netherlands, and Rockville. Md., 1980; p. 182.
Sanchez De la Peña S., Halberg F., Ungar F.: Pineal chronomodulation the feed sideward— Clin. Chem. Newsletter2, 129, 1982.
Sanchez de la Peña S., Halberg F., Ungar F., Haus E., Lakatua D., Sanchez E., Vecsei P., Scheving L. E.: Circadian rhythmic pineal modulation of pituitary effect on murine adrenal corticosterone productionin vitro—Brain Res. Bull. (In press).
Sanchez de la Peña S., Ungar F., Halberg F., Sanchez E., Yunis E., Vecsei P.: Circadian and infradian variation in murine adrenal corticosterone production—a test system for Synchrodyn. In:Takahashi R., Walker C., Halberg F. (Eds): Toward chronopharmacology. Proc. 8th IUPHAR Congr. and Sat. Symposia, Nagasaki, July 27–28, 1981. Pergamon Press, Oxford-New York, 1982; p. 319.
Scheving L. E., Tsai T. H., Powell E. W., Pasley J. N., Halberg F., Dunn J.: Bilateral lesions of suprachiasmatic nuclei affect circadian rhythms in [3H]-thymidine incorporation into deoxyribonucleic acid in mouse intestinal tract, mitotic index of corneal epithelium and serum corticosterone—Anat. Rec. (In press).
Smolensky M. H., Halberg F., Pitts G. C., Nelson W.: The chronopharmacology of methylprednisolone: clinical implications of animal studies with special emphasis upon the moderation of growth inhibition by timing to circadian rhythms. In:Smolensky M. H., Reinberg A., McGovern J. P. (Eds): Recent advances in the chronobiology of allergy and immunology. Pergamon Press, Oxford, 1981; p. 137.
Soutar C. A., Costello J., Ihaduola O., Turner-Warwick M.: Nocturnal and early morning asthma. Relationship to plasma corticosteroid and response to cortisol infusion—Thorax30, 436, 1975.
Uezono K., Sackett-Lundeen L., Kawasaki T., Haus E.: Circaseptan rhythm in clinically healthy human subjects—Int. J. Chronobiol.7, 340, 1981.
Ungar F., Halberg F.: Circadian rhythm in thein vitro response of mouse adrenal to adrenocorticotropic hormone—Science137, 1058, 1962.
Weitzman E. D.: Circadian rhythms and episodic hormone secretion in man—Ann. Rev. Med.27, 225, 1976.
Zbiegieni B. M.: Diurnal and seasonal changes in ascorbic acid level in adrenal glands of laboratory mice—Bull. Acad. pol. Sci. (Physiol.)27, 653, 1980.
Author information
Authors and Affiliations
Additional information
Contribution invited and delivered by the Senior Author at a Symposium coorganized by the American Society of Toxicology and the Society for Experimental Pharmacology and Therapeutics, held in Louisville, Kentucky, USA, on August 15–19, 1982.
Rights and permissions
About this article
Cite this article
Angeli, A., Carandente, F. & Halberg, F. Temporal aspects of glucocorticoid action and clinical implications. La Ricerca Clin. Lab. 13, 203–217 (1983). https://doi.org/10.1007/BF02904834
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02904834